wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36614435-60B309BE-30DC-4926-9EF2-2EA9D0C9E07B
Q36614435-60B309BE-30DC-4926-9EF2-2EA9D0C9E07B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36614435-60B309BE-30DC-4926-9EF2-2EA9D0C9E07B
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
P2860
Q36614435-60B309BE-30DC-4926-9EF2-2EA9D0C9E07B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36614435-60B309BE-30DC-4926-9EF2-2EA9D0C9E07B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b82bd0af0a60dad51938932f906857baeed4cdd3
P2860
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.